News

News
Other news

ONL Therapeutics Closes $46.9 Million in Series B Financing to Advance ONL1204 into Three Retinal Disease Indications

Read full story
Partner news

MacroGenics Enters Research Collaboration with Janssen to Develop Novel DART® Molecule

Read full story
Other news

XWPharma Names Michael M. Morrissey, PhD to Board of Directors

Read full story
Partner news

Australian National University Announces Research Project with Janssen to Help Develop New Methods for Measuring and Monitoring Type 1 Diabetes

Read full story
Partner news

Symvivo Corporation Announces Research Agreement with Janssen to Offer Novel Approach to Therapeutic Protein Delivery

Read full story
Partner news

CHO Plus Announces Research Collaboration Agreement with Janssen to Improve Manufacturing of Therapeutic Proteins

Read full story
Partner news

UK Biobank launches one of the largest scientific studies measuring circulating proteins, to better understand the link between genetics and human disease

Read full story
Partner news

Xencor Enters Collaboration with Janssen with Aim to Discover Novel CD28 Bispecific Antibodies for the Treatment of Prostate Cancer

Read full story
Partner news

Janssen Acquires Rights to Novel Gene Therapy, Pioneering Treatment Solutions for Late-Stage Age-Related Macular Degeneration

Read full story
Other news

Big Data Institute announces collaboration with Janssen to advance understanding of human genetic signatures

Read full story
Partner news

Koa Health to collaborate with Janssen: Official press release

Read full story
Other news

Cue’s Molecular, Point-of-Care COVID-19 Tests Deployed to Five States in HHS and DOD Pilot Program

Read full story
In the media

Innovating for the future of human health

Read full story
Partner news

BioMed X Institute starts new project in immunology research with Janssen

Read full story
Other news

DERMALA Announces $6.73 Million Series A Financing to Expand and Scale Company’s Personalized Microbiome-Based Solutions for Acne and Other Skin Conditions

Read full story